Efficacy of Risperidone in Treating Anorexia Nervosa

Risperidone has been explored as a treatment option for children and adolescents with anorexia nervosa, but recent findings highlight its limited efficacy. A significant study involving 120 young patients revealed that, despite being well-tolerated, risperidone did not produce meaningful improvements in body mass index or psychological health compared to untreated individuals. Retention rates for those on risperidone were concerning, with only 50% remaining on the medication after three months and a mere 9.5% after one year. These results suggest that while risperidone may be safe, its role as an effective treatment for this demographic is questionable, necessitating further exploration of alternative options.